ScholarIQanswers from OpenAlex

Revision Rates and Symptom Trends Following Endoscopic Sinus Surgery: Impact of Race on Outcomes

PaperCitations, authors & open-access status

Revision Rates and Symptom Trends Following Endoscopic Sinus Surgery: Impact of Race on Outcomes is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Revision Rates and Symptom Trends Following Endoscopic Sinus Surgery: Impact of Race on Outcomes have?

ScholarIQcitation count

Revision Rates and Symptom Trends Following Endoscopic Sinus Surgery: Impact of Race on Outcomes has 12 citations in the OpenAlex counts ScholarIQ stores.

When was Revision Rates and Symptom Trends Following Endoscopic Sinus Surgery: Impact of Race on Outcomes published?

ScholarIQyear

Revision Rates and Symptom Trends Following Endoscopic Sinus Surgery: Impact of Race on Outcomes has 2023 year in the ScholarIQ index.

What is the open-access status of Revision Rates and Symptom Trends Following Endoscopic Sinus Surgery: Impact of Race on Outcomes?

ScholarIQoa status

Revision Rates and Symptom Trends Following Endoscopic Sinus Surgery: Impact of Race on Outcomes has closed oa status in the ScholarIQ index.

What is the DOI of Revision Rates and Symptom Trends Following Endoscopic Sinus Surgery: Impact of Race on Outcomes?

ScholarIQdoi

The DOI for Revision Rates and Symptom Trends Following Endoscopic Sinus Surgery: Impact of Race on Outcomes is on the source record.

What is the PMID of Revision Rates and Symptom Trends Following Endoscopic Sinus Surgery: Impact of Race on Outcomes?

ScholarIQpmid

The PMID for Revision Rates and Symptom Trends Following Endoscopic Sinus Surgery: Impact of Race on Outcomes is on the source record.

What is the OpenAlex record for Revision Rates and Symptom Trends Following Endoscopic Sinus Surgery: Impact of Race on Outcomes?

ScholarIQopenalex

The OpenAlex for Revision Rates and Symptom Trends Following Endoscopic Sinus Surgery: Impact of Race on Outcomes is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial